TechCrunch @TechCrunch
Armed with $6.3 million in new pre-seed capital, Synonym #Biotechnologies has begun the development phase for its first productized #biomanufacturing facilities for non-pharmaceutical applications https://t.co/ZcdLHH7EM7 — PolitiTweet.org